The whole-genome sequencing of canine osteosarcoma samples performed by Gardner et al. [100] revealed recurrent alterations in the SETD2 gene, including somatic point mutations, deletions, and chromosomal translocations in approximately 42% of cases. This evidence concerns the gene SETD2 and osteosarcoma.